John Nuss - Dec 27, 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Austin Rutherford, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Dec 27, 2024
Transactions value $
-$49,841
Form type
4
Date filed
12/30/2024, 05:33 PM
Previous filing
Dec 19, 2024
Next filing
Jan 3, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale -$49.8K -21.1K -4.35% $2.36 465K Dec 27, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 21,119 shares sold in the price range of $2.36 to $2.365. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.